
Want to live to 100? Skip the gym, this daily habit matters more; longevity expert reveals
The Surprising Power of Everyday Movement
A Sitting Threat You Can't Outrun
You Might Also Like:
What is a 'sedentary lifestyle'? Cardiologist warns that too much sitting may be as harmful as smoking
Rethink What's on Your Plate
You Might Also Like:
Why you keep waking up at 3 a.m.? The hidden sleep crisis millions are Googling right now
Sleep: Your Nighttime Lifeline
Know Thyself—And Your Family
Why It Matters Now?
What if the secret to a longer, healthier life wasn't tucked away in a gym, but instead hiding in plain sight—right in your daily routine? According to leading longevity researcher Dr. Gareth Nye, a long life isn't just about clean genes or killer workouts. It's about what you do between the workouts that counts.Dr. Nye, a biomedical expert, challenges the age-old belief that intense exercise is the golden ticket to longevity. Instead, he champions what he calls 'whole activity levels'—a fancy way of saying keep moving throughout the day. Sitting for hours at a desk, even if balanced with a daily gym session, may still be putting your health at risk.'People who live longer tend to have a higher activity level in their day-to-day lives, rather than relying on structured exercise programs,' Dr. Nye explained while talking to The Mirror. 'It's about avoiding prolonged periods of sitting and making your entire day more dynamic.'This could mean taking walking breaks between tasks, using a standing desk, or even tweaking your commute to sneak in more steps. The goal? Make movement second nature.Recent studies back this idea, showing that extended periods of inactivity—regardless of how much you work out—can increase the risk of serious health conditions, including Alzheimer's. In essence, your body doesn't forgive long stretches of stillness, even if you're clocking an hour on the treadmill later.The problem with high-intensity workouts, Dr. Nye points out, is sustainability. Many people struggle to stick to them long term, while simply staying active throughout the day is a more realistic, beneficial approach.Physical movement is only part of the story. Dr. Nye emphasizes a return to natural, minimally processed foods . He warns against a diet high in saturated fats, salt, and sugar, and flags processed meats like bacon and ham as significant threats due to their link to bowel cancer.'The less processing, the better,' he says. 'Free-range or organic meat and vegetables are ideal. The more processing involved, the more detrimental it is to the body.'Even for those on a tight schedule or budget, he recommends frozen fruits and vegetables as a practical alternative to fresh produce. 'They're just as beneficial and often easier to add into meals,' he adds.If there's one thing you can't afford to skimp on, it's sleep. According to Dr. Nye, getting less than seven hours a night increases your risk of death by 12 percent. But don't oversleep either—those regularly clocking more than eight hours face an even higher 30 percent risk.'Regular sleep patterns are key,' he stresses. 'They help regulate the body's internal systems, which in turn can impact how long you live.'Lack of quality sleep has been linked to obesity, heart disease, and Type 2 diabetes, all of which can chip away at life expectancy.Finally, Dr. Nye underscores the role of genetics in lifespan. While only 20 to 30 percent of longevity is influenced by DNA, knowing your family history can offer crucial insight into potential health risks.Routine check-ups and, in some cases, genetic testing can help identify predispositions to certain conditions early on. 'Roughly 40 percent of life expectancy can be traced through generations,' Dr. Nye says. 'If your grandparents and parents lived long, healthy lives, you've got a better shot.'However, he cautions that genetic testing can also uncover unexpected information about family members, so it's essential to weigh the emotional and social implications.Dr. Nye's advice lands at a time when life expectancy gains in many countries have started to plateau—or even decline. Obesity, sedentary lifestyles, and processed diets are contributing to this shift, despite years of progress in healthcare and medicine.While the latest data may be disheartening, Dr. Nye's message is clear and empowering: longevity isn't just about luck. It's about small, sustained choices—choosing stairs over the elevator, frozen veggies over fast food, and bedtime over binge-watching. So next time you're stuck at your desk, remember—living to 100 might just start with standing up.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hans India
5 hours ago
- Hans India
Alzheimer's gene therapy shows promise to prevent brain damage
New Delhi: A novel gene therapy for Alzheimer's disease, which showed promise to protect the brain from damage and preserve cognitive function, has renewed hope for millions of patients with the neurodegenerative disease. Worldwide, approximately 57 million people live with dementia, and Alzheimer's disease is the most common cause, accounting for 60-70 per cent of cases. Alzheimer's occurs when abnormal proteins build up in the brain, leading to the death of brain cells and declines in cognitive function and memory. While current treatments can manage symptoms of Alzheimer's, the new gene therapy aims to halt or even reverse disease progression, said researchers from the University of California San Diego School of Medicine. They noted that, unlike existing treatments for Alzheimer's that target unhealthy protein deposits in the brain, the new approach could help address the root cause of Alzheimer's disease by influencing the behaviour of brain cells themselves. The study investigated the effect of hippocampal SynCav1 delivery in two distinct preclinical mice models. The results, published in the journal Signal Transduction and Targeted Therapy, showed that delivering the treatment at the symptomatic stage of the disease preserved hippocampal-dependent memory -- a critical aspect of cognitive function that is often impaired in Alzheimer's patients. Further, the finding stated that compared to healthy mice of the same age, the treated mice also had a similar pattern of gene expression. This suggests that the treatment has the potential to alter the behaviour of diseased cells to restore them to a healthier state. 'While multiple newly FDA-approved treatments focus on targeting amyloid-beta clearance in Alzheimer's patients, the therapeutic value of SynCav1 lies in its ability to protect vulnerable neurons and augment cellular responses -- mechanisms that differ from currently approved therapies,' said the researchers in the paper. Due to the multitude of neurotoxicity in the Alzheimer's brain, the team called for further studies to investigate SynCav1's therapeutic role when combined with amyloid-targeted drugs to enhance clinical outcomes.


Time of India
7 hours ago
- Time of India
Curing the incurable: How is AI revolutionising treatment for ALS, Alzheimer's and Dementia?
ALS Detection: Predicting chances of developing Alzheimer's years ahead: Live Events Advancements in Dementia Research with AI: Enhanced patient care with AI-enabled technology: AI ushers in new hope in the fight against neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer's, and various forms of dementia. Through the predictive capabilities of machine and deep learning (two subsets of AI), healthcare professionals today are able to predict the onset of these ailments years prior. Enabling early detection uncovers hidden risk factors and allows personalised care, thereby transforming the landscape of diagnosis and treatment. The traditional method of diagnosing ALS stands to be an unnecessarily long procedure, inculcating unwanted spinal surgeries, carpal tunnel releases, and immunotherapies; redundant tests and labs; merely to exclude every other possible condition that could align with the symptoms the patient shows. As a result, this procedure could take up to a year or even more. Before this procedure procures information that could successfully diagnose the patient, the damage stands to be made, making it too late for any treatment to garner AI and its ability to analyse vast amounts of data enable identifying early signs of the disease. For example, the uses AI to observe speech patterns, motor abilities, and the individual's manner of walking. The AI notices subtle changes portrayed by the individual that the human eye tends to have trouble noticing until made explicitly evident. Integrating AI in the diagnosis of ALS makes it faster, giving patients more time to treat themselves with an increased amount of hope than with traditional also enables diagnosis of patients who do not have any mentions of ALS in their medical records but could have undiagnosed ALS by recognising patterns in their medical histories. This reduces time and allows faster intervention, leading to better patient outcomes. Scientists at UCSF have developed a way to predict Alzheimer's disease up to seven years before the symptoms start to appear via having machine learning analyse patient records. The machine learning analyses the patient's electronic health records and also considers factors such as high cholesterol, osteoporosis (especially in women), depression, and vitamin D deficiency, thereby fostering a success rate of nearly 72%.This early prediction model allows patients to try various treatment plans, provides them the liberty to hope for improvement, and also lets them make lifestyle modifications that could procure delays or mitigations in the progression of Alzheimer' is an amalgamation of various diseases caused by various underlying disorders like Alzheimer's, vascular dementia frontotemporal dementia , and more. Each kind of dementia varies with the different ancestral backgrounds, environmental exposures, and genetics. With this kind of complexity, it is inevitable that there will occur a large data set. Thereby, making the inculcation of AI into dementia-related studies essential, as emphasised by the NIH's Center for Alzheimer's and Related Dementias (CARD). AI's capacity to analyse complex and large datasets uncovers subtle patterns in data, aiding in early detection and diagnosis of various dementia types and understanding their AI is exceptional in identifying previously unknown genetic risk factors, enhancing healthcare professionals' understanding of the ailment's biology, and paving the way for personalised from being entangled in vital research-related roles and predictive diagnosis-related roles in healthcare, AI is also equally entangled in caregiving. AI-powered robots are being explored by researchers to support dementia patients in their daily lives, promoting independence and reducing familial burden. These robots are being studied/built with the aim to respect the autonomy and dignity of patients while providing practical help with tasks such as medication reminders and emergency alerts. Innovations such as these are bound to be an improving agent for the patients' quality of life and offer reassurance to the existence within this field shall potentially revolutionise the approaches taken towards the ailments deemed incurable, offering hope for earlier diagnoses, personalised treatments, and improved patient outcomes. As studies advance and technology evolves, AI is equipped to become an invulnerable warrior in this ongoing battle against ALS, Alzheimer's, and dementia of other forms ( source ).


Economic Times
8 hours ago
- Economic Times
Curing the incurable: How is AI revolutionising treatment for ALS, Alzheimer's and Dementia?
AI ushers in new hope in the fight against neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer's, and various forms of dementia. Through the predictive capabilities of machine and deep learning (two subsets of AI), healthcare professionals today are able to predict the onset of these ailments years prior. Enabling early detection uncovers hidden risk factors and allows personalised care, thereby transforming the landscape of diagnosis and treatment. The traditional method of diagnosing ALS stands to be an unnecessarily long procedure, inculcating unwanted spinal surgeries, carpal tunnel releases, and immunotherapies; redundant tests and labs; merely to exclude every other possible condition that could align with the symptoms the patient shows. As a result, this procedure could take up to a year or even more. Before this procedure procures information that could successfully diagnose the patient, the damage stands to be made, making it too late for any treatment to garner improvements. However, AI and its ability to analyse vast amounts of data enable identifying early signs of the disease. For example, the uses AI to observe speech patterns, motor abilities, and the individual's manner of walking. The AI notices subtle changes portrayed by the individual that the human eye tends to have trouble noticing until made explicitly evident. Integrating AI in the diagnosis of ALS makes it faster, giving patients more time to treat themselves with an increased amount of hope than with traditional also enables diagnosis of patients who do not have any mentions of ALS in their medical records but could have undiagnosed ALS by recognising patterns in their medical histories. This reduces time and allows faster intervention, leading to better patient at UCSF have developed a way to predict Alzheimer's disease up to seven years before the symptoms start to appear via having machine learning analyse patient records. The machine learning analyses the patient's electronic health records and also considers factors such as high cholesterol, osteoporosis (especially in women), depression, and vitamin D deficiency, thereby fostering a success rate of nearly 72%. This early prediction model allows patients to try various treatment plans, provides them the liberty to hope for improvement, and also lets them make lifestyle modifications that could procure delays or mitigations in the progression of Alzheimer's. Dementia is an amalgamation of various diseases caused by various underlying disorders like Alzheimer's, vascular dementia, Lewy body dementia, frontotemporal dementia, and more. Each kind of dementia varies with the different ancestral backgrounds, environmental exposures, and genetics. With this kind of complexity, it is inevitable that there will occur a large data set. Thereby, making the inculcation of AI into dementia-related studies essential, as emphasised by the NIH's Center for Alzheimer's and Related Dementias (CARD). AI's capacity to analyse complex and large datasets uncovers subtle patterns in data, aiding in early detection and diagnosis of various dementia types and understanding their interrelations. Moreover, AI is exceptional in identifying previously unknown genetic risk factors, enhancing healthcare professionals' understanding of the ailment's biology, and paving the way for personalised therapies. Apart from being entangled in vital research-related roles and predictive diagnosis-related roles in healthcare, AI is also equally entangled in caregiving. AI-powered robots are being explored by researchers to support dementia patients in their daily lives, promoting independence and reducing familial burden. These robots are being studied/built with the aim to respect the autonomy and dignity of patients while providing practical help with tasks such as medication reminders and emergency alerts. Innovations such as these are bound to be an improving agent for the patients' quality of life and offer reassurance to the caregivers. AI's existence within this field shall potentially revolutionise the approaches taken towards the ailments deemed incurable, offering hope for earlier diagnoses, personalised treatments, and improved patient outcomes. As studies advance and technology evolves, AI is equipped to become an invulnerable warrior in this ongoing battle against ALS, Alzheimer's, and dementia of other forms (source). Disclaimer Statement: This content is authored by a 3rd party. The views expressed here are that of the respective authors/ entities and do not represent the views of Economic Times (ET). ET does not guarantee, vouch for or endorse any of its contents nor is responsible for them in any manner whatsoever. Please take all steps necessary to ascertain that any information and content provided is correct, updated, and verified. ET hereby disclaims any and all warranties, express or implied, relating to the report and any content therein.